Quantitative Insights was created rapidly to commercialize recent advancements in computer-aided diagnosis software (CAD) for early detection, diagnosis, and prognosis of breast and other cancers. The firm's lead product is the industry's first fully integrated multi-modality workstation, and is broadly protected by a robust patent portfolio. This technology further benefits from Quantitative Insights' partnerships with key-opinion leaders in the CAD space and the healthcare reform trends that are favorable to both diagnostic and Healthcare IT solutions. Quantitative Insights is the winner of the 2010 Chicago Biomedical Consortium Business Plan Competition, was selected as Chicago Booth's top healthcare company in the 2010 New Venture Challenge, is an alpha participant in the Chicago Innovation Mentors Program, and is part of the National Science Foundation's Innovation Accelerator
